HomeAI · summaries
Storia in 2 fonti
Third death in China’s expedited trials; Merck and Moderna’s cancer vaccine win; and more
Welcome back to Endpoints Weekly! Merck and Moderna dominated the headlines this week with topline results for their personalized cancer vaccine. Check out our team’s detailed analysis on the results ...
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
statnews.com
Experts scrutinize Huidagene’s disclosures after patient death
Merck and Moderna's mRNA cancer vaccine, an expected nominee to lead the FDA, and more biotech news from The Readout
- ·
endpoints.news
Third death in China’s expedited trials; Merck and Moderna’s cancer vaccine win; and more
Welcome back to Endpoints Weekly! Merck and Moderna dominated the headlines this week with topline results for their personalized cancer vaccine. Check out our team’s detailed…